The Biden administration is moving to require patients to be evaluated by a physician in person before receiving prescriptions for some controlled medications, including Adderall and OxyContin.

The proposal would reverse a policy enacted during the coronavirus pandemic that allowed doctors to prescribe these medications through telehealth appointments. The move will make it more difficult for Americans to access some drugs used for treating pain and mental health disorders.

The Drug Enforcement Administration announced the proposed rules on Friday, which state that telehealth flexibilities will be extended for common, non-controlled medications but schedule II medications and narcotics will be prohibited without an in-person appointment.

Patients must visit a doctor in person at least once to receive an initial prescription for drugs the federal government believes have the highest potential for abuse, including Vicodin, OxyContin, Adderall and Ritalin. Refills for these medications could still be prescribed over telehealth appointments.

NEW YORK NURSE ACCUSED OF SLAMMING BABY ONTO BASSINET FIRED, UNDER INVESTIGATION

Doctors will only be able to prescribe controlled medications like Ambien and Xanaxas, as well as medications used to treat opioid addiction, for 30 days. Any refills for these drugs will require an in-person evaluation.

Should the government force everyone to get vaccinated?

By completing the poll, you agree to receive emails from Being Healthy News, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.

The rules aim to maintain expanded access to telehealth, which has been crucial for millions of patients, particularly those living in rural areas, while also balancing safety.

“DEA is committed to ensuring that all Americans can access needed medications,” DEA Administrator Anne Milgram said in a statement. “The permanent expansion of telemedicine flexibilities would continue greater access to care for patients across the country while ensuring the safety of patients. DEA is committed to the expansion of telemedicine with guardrails that prevent the online overprescribing of controlled medications that can cause harm.”

Continue Reading >>

H/T Fox News (read more at FoxNews.com)

The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of Being Healthy News. Contact us for guidelines on submitting your own commentary.